The Global Salmonella Testing Market is estimated to be valued at US$ 2.91 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Salmonella testing identifies the presence of Salmonella bacteria, which can cause serious foodborne illnesses like typhoid fever, paratyphoid fever, and food poisoning. Rapid detection of Salmonella contamination is important for public health as it enables the removal of contaminated foods and prevents outbreaks. Salmonella testing kits offer promising results within 24-48 hours through enzyme immunoassays, polymerase chain reaction (PCR), and other methods. The growing outbreaks of foodborne illnesses have increased the need for reliable and affordable Salmonella testing solutions across the food processing and healthcare industries.
Market key trends:
One of the major trends spurring the market growth is the increasing regulatory focus on food safety. Stringent regulations imposed by authorities like FDA mandate regular Salmonella testing of foods. Technological advancements are also fueling the market expansion. The introduction of PCR-based rapid tests has streamlined the testing process, providing results within hours. Furthermore, the integration of microfluidics enables compact testing with minimal sample volume. The rising awareness about food safety among consumers has prompted food businesses to strengthen their testing protocols to protect their brand image. Growing outbreaks worldwide further validate the importance of robust surveillance through extensive Salmonella testing.
Porter’s Analysis
Threat of new entrants: The salmonella testing market requires high capital investments for equipment and R&D. Regulatory compliance is also very stringent. Therefore threat of new entrants is low.
Bargaining power of buyers: The presence of many suppliers who provide similar products gives buyers bargaining power through competition. However, stringent regulations minimize scope for buyer bargaining.
Bargaining power of suppliers: Large global players dominate the supply side. This gives them influence over pricing and product offerings. However, availability of substitutes keeps supplier power in check.
Threat of new substitutes: Though alternatives like ELISA and PCR exist, no substitute can match rapidity, accuracy and affordability provided by lateral flow assays. Threat from new substitutes is moderate.
Competitive rivalry: The global salmonella testing market is highly consolidated with large players. Market saturation prompts intense competition through pricing, innovation and expansion.
Key Takeaways
The Global Salmonella Testing Market is expected to witness high growth, exhibiting CAGR of 7.8% over the forecast period, due to increasing foodborne diseases and stringent food safety regulations globally.
Regionally, North America dominated the salmonella testing market in 2023 attributed to supportive regulatory scenario, increasing outbreaks and technologically advanced laboratories. Asia Pacific is anticipated to be the fastest growing market owing to growing healthcare infrastructure and rising health awareness.
Key players operating in the salmonella testing market are Thermo Fisher Scientific, Merck KGaA (known as MilliporeSigma in the United States and Canada), bioMérieux SA, Neogen Corporation, QIAGEN N.V., 3M Company, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories International Inc., LabCorp, R-Biopharm AG, Biomerica Inc., Zeulab S.L. Companies focus on new product innovation and regional expansion to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it